Cardinal Healthvs.McKesson
CAH vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
McKesson is about 1.7× larger than Cardinal Health by market cap; McKesson trades at the lower P/E (19.8 vs 35.5); year to date, Cardinal Health leads (+14.7% vs −1.7%).
Side by side
| CAH | MCK | |
|---|---|---|
| Market cap | $55.2B | $94.4B |
| Price | $235.80 | $805.96 |
| Today | +0.9% | +1.7% |
| Return YTD | +14.7% | −1.7% |
| Return 1Y | +45.4% | +12.8% |
| P/E | 35.5 | 19.8 |
| P/S | 0.2 | 0.2 |
| P/B | 55.3 | 16.0 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Cardinal HealthCAH
American pharmaceutical wholesaler and medical products supplier — distributes medicines and manufactures medical consumables.
Full CAH profile →McKessonMCK
American pharmaceutical wholesaler — one of the largest distributors of medicines to pharmacies, hospitals and clinics in the US.
Full MCK profile →More comparisons in Distribution & pharmacy infrastructure
See where CAH and MCK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →